PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV. (Q30401566)

21 June 2017

PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV. (English)

1 reference

21 June 2017

0 references

1 reference

Wei-wei Gai

1

1 reference

21 June 2017

Yan Zhang

2

1 reference

21 June 2017

Di-han Zhou

3

1 reference

21 June 2017

Yao-qing Chen

4

1 reference

21 June 2017

Jing-yi Yang

5

1 reference

21 June 2017

Hui-min Yan

6

1 reference

21 June 2017

7 April 2011

1 reference

21 June 2017

1 reference

21 June 2017

26

1 reference

21 June 2017

2

1 reference

21 June 2017

81-94

1 reference

https://scigraph.springernature.com/pub.10.1007/s12250-011-3183-z

21 June 2017

0 references

cites work

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Mucosal immunity and tolerance: relevance to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Aetiology: Koch's postulates fulfilled for SARS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Effects of different immunization protocols and adjuvant on antibody responses to inactivated SARS-CoV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Interaction of antigens and antibodies at mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Pathogenesis of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Immunization against bacterial diseases of the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Association of HLA class I with severe acute respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Intracellular neutralization of virus by immunoglobulin A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

21 January 2018

1 reference

12 December 2020

The effect of interferon on rabies infection of animals

1 reference

12 December 2020

Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase

1 reference

12 December 2020

Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes.

1 reference

12 December 2020

An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice

1 reference

12 December 2020

PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA

1 reference

12 December 2020

Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells

1 reference

12 December 2020

Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans

1 reference

12 December 2020

Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses

1 reference

12 December 2020

Poliomyelitis in the United States: the final chapter?

1 reference

12 December 2020

Immunologic‐mediated Protection of Trypanosoma congolense‐Infected Mice by Polyribonucleotides

1 reference

12 December 2020

10.1007/S12250-011-3183-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

21 June 2017

0 references

0 references

1 reference